ConsulTech Logo

New IMI calls in 2020

The European public-private partnership „Innovative Medicines Initiative“ (IMI2) has published new calls with the following topics:
Call 20
  • early diagnosis, prediction of radiographic outcomes and development of rational, personalised treatment strategies to improve long-term outcomes in Psoriatic Arthritis
  • innovations to accelerate vaccine development and manufacture
  • Academia and industry united innovation and treatment for tuberculosis (UNITE4TB)
  • tumour plasticity
  • proton versus photon therapy for oesophageal cancer – a trimodality strategy
  • handling of protein drug products and stability concerns

The deadline for call 20 is May 12. Here is the link to the call text.

We recommend to start already now assembling a powerful and competitive consortium. As we have great experience in supporting consortia (demonstrated through our participation in the IMI-PainCare project) we are certainly able to assist in the entire process of the setting up and file the application.